Product Information
POTASSIUM CITRATE ER 10 MEQ TB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1813 per EA under NDC 16571086501. Its NADAC has been published 55 times since Jun 11, 2025.
Strength
1080 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571086501
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077440On Market Since
12/15/2024
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 10 MEQ TB has been published 55 times since Jun 11, 2025, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1813 per EA |
|---|---|
| All-time high | $0.2205 (Jun 11, 2025) |
| All-time low | $0.1666 (Sep 17, 2025) |
| 52-week high | $0.2180 |
| 52-week low | $0.1666 |
| Median price | $0.1778 |
| Average price | $0.1812 |
| Largest weekly change | -10.5% (Jul 23, 2025) |
| Weeks tracked | 55 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the potassium citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 10 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 10 MEQ TB, manufactured by Rising Pharma Holdings Inc., is $0.1813 per EA (NDC 16571086501), effective Jun 24, 2026.
How has the price of POTASSIUM CITRATE ER 10 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has declined 17.8%. It has been tracked across 55 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 10 MEQ TB?
Since Jun 11, 2025, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has ranged from a low of $0.1666 (Sep 17, 2025) to a high of $0.2205 (Jun 11, 2025), with a median of $0.1778 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 10 MEQ TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of POTASSIUM CITRATE ER 10 MEQ TB, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CITRATE ER 10 MEQ TB?
POTASSIUM CITRATE ER 10 MEQ TB (NDC 16571086501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification